Nurofen firm lifts sales targets

Household goods and drugs giant Reckitt Benckiser saw a return to sales growth in Europe and North America as it recovered from a slow cold and flu season earlier this year.

Reckitt said like-for-like sales in the transatlantic region rose 2% in the third quarter after a 1% fall in the first half when fewer cases of the common cold and flu impacted demand for its Strepsils and Nurofen pain-relief range at the start of 2012.
%VIRTUAL-SkimlinksPromo%